I think saying SUN S.P. is dependent on special divvy is very narrow call. It has a nice safe divvy level already: each of 4 brokers I've reviewed since Motley/OM call have ranked SUN as best bet in the insurance sector going into lower AUD and RBA interest prediction. So a special divvy would thrust it up, without special divvy I think it will see into's/SMSFs investing as a "defensive growth" (sorry about teh oxymoron) stock in coming 6 months.
QBE is 40% Brexit exposed - it's virtually a spec stock until everyone knows Brexit/Banking/employment in UK.
Whereas SUN has '17 growth predictions and only local exposure, so US dollar/Brexit risk factors greatly reduced from IAG/QBE risks will amke it very attractive to medium/long hedge investors (yes I know, despite its insurance industry risk).
Either of us could be wrong JC, but if I'm wrong I'm wrong along with 5 brokers/analysts.
Nothing personal JC, I just bit at your introduction to your statement "no..." which is kinda patronising while your pumping another stock.
- Forums
- ASX - By Stock
- SUN
- SUN - Time to Buy??
SUN - Time to Buy??, page-67
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SUN (ASX) to my watchlist
|
|||||
Last
$16.98 |
Change
0.010(0.06%) |
Mkt cap ! $21.60B |
Open | High | Low | Value | Volume |
$17.04 | $17.12 | $16.83 | $30.77M | 1.815M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4256 | $16.98 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.99 | 7692 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 83 | 16.940 |
1 | 250 | 16.920 |
1 | 7692 | 16.910 |
6 | 13258 | 16.900 |
1 | 270 | 16.890 |
Price($) | Vol. | No. |
---|---|---|
16.990 | 7692 | 2 |
17.000 | 3115 | 4 |
17.010 | 8203 | 2 |
17.020 | 7896 | 2 |
17.030 | 201 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
SUN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online